Bioinsopired Mucoadhesive Polymers for Oral Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 512
Special Issue Editors
Interests: drug delivery systems; colloids; hydrogels; thermogelling systems; mucoadhesion; surfactants; rheology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Oral administration is one of the most widely used administration routes for local and systematic drug delivery, but drugs administered in this manner often face harsh conditions in the gastrointestinal (GI) tract, leading to their degradation and limited bioavailability. Optimal drug delivery systems are thus needed to protect drugs from degradation and enhance their distribution and penetration through GI barriers. One of the current trends in the design and development of drug delivery systems is the utilization of biocompatible and biodegradable multifunctional polymers with mucoadhesive properties. Mucoadhesive formulations for oral drug delivery exhibit many advantages over conventional orally delivered drugs, such as improved bioavailability and adherence to oral mucosa and enhanced retention time and permeability. This Special Issue aims to cover the next generation of polymers, with an emphasis on bioinspired and biomimetic polymers and their derivatives, which exhibit mucoadhesive properties, with an additional focus on novel properties for the further improvement of drug retention and bioavailability and smart drug delivery. Nano-based hybrid formulations conjugated with mucoadhesive polymers will also be highlighted.
Original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Bioinspired mucoadhesive polymers;
- Mucoadhesive hydrogels;
- Hybrid mucoadhesive nanoparticles;
- Nanomedicines;
- Design of drug delivery systems for local targeting (ulcers, IBD, etc.);
- Drug release profiles;
- In vitro, ex vivo and in vivo testing.
We look forward to receiving your contributions.
Dr. Giulia Bonacucina
Dr. Atiđa Selmani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mucoadhesion
- bioinspired polymers
- hybrid mucoadhesive systems
- oral administration
- targeted drug delivery
- controlled release
